Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Jeremias: Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneou.... (0.34 sec) 

Balancing efficacy and safety of drug-eluting stents in patients undergoing …

- annals.org
A Jeremias, A Kirtane - Annals of internal medicine, 2008 - Am Coll Physicians
Drug-eluting stents reduce the occurrence of in-stent restenosis and the need for subsequent
target vessel revascularization compared with bare-metal stents. However, the safety of
drug-eluting stents has been called into question because of an apparent increase in late ...
Cited by 9 - Related articles - BL Direct - All 8 versions

Neurological Complications of Cardiac Surgery.

- critcaremed.com
RFMD Gottesman, GMMD McKhann, CWMD … - Seminars in …, 2008 - thieme-connect.com
Neurological injury resulting from cardiac surgery has a range of manifestations from focal neurological
deficit to encephalopathy or coma. As the safety of drug-eluting stents comes into question, more
patients will likely undergo coronary artery bypass graft surgery. These projections, along ...
Related articles - All 9 versions

Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in …

- adisonline.com
F Canoui-Poitrine, G Jeanblanc, C Alberti, P … - … and Health Policy, 2009 - ingentaconnect.com
1 Assistance Publique – Hopitaux de Paris (AP-HP), Henri Mondor Hospital, EA 4393, Paris
12 Medical School, Créteil, France 2 Université de Lyon, Hospices Civils de Lyon, Lyon, France
3 AP-HP, Unit of Clinical Epidemiology, Robert Debre Hospital, Paris, France 4 INSERM, ...
Related articles - All 9 versions

Antiplatelet Therapy for the Secondary Prevention of Acute Coronary Syndrome


G Recommendations - US Pharm, 2009 - uspharmacist.com
Acute coronary syndrome (ACS), a manifestation of CHD, is a spectrum of ailments that encompasses
unstable angina (UA) and acute myocardial infarction (MI), with or without ST-segment elevation
(STEMI or NSTEMI). ACS is the end result of atherosclerosis, a diffuse disease of ...
Related articles - Cached - All 6 versions

Bare-Metal Versus Drug-Coated Intracoronary Stents in Clinical Practice: Are …


SS Naidu - vasculardiseasemanagement.com
The development of bare-metal stents (BMS) and optimal post-procedure antiplatelet therapy
in the mid 1990s resulted in marked reductions in acute and subacute stent thrombosis, bleeding
complications, negative remodeling, and acute vessel recoil, and a consequent dramatic ...
Related articles - Cached - All 2 versions

[PDF] PHArMACO-ACTIVES 1ère partie: analyse dans la population générale


E COrONAIrES - Rev Med Liege, 2008 - rmlg.ulg.ac.be
L'angioplastie percutanée coronaire constitue une alternative intéressante au pontage
aorto- coronaire en raison de son caractère beaucoup moins invasif. Elle a bénéficié de progrès
tech- niques au cours des 10 dernières années avec le recours de plus en plus fréquent ...
Related articles - View as HTML - All 2 versions

Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting …


RC Edgell, DR Yavagal, D Drazin, R Olivera, AS … - J …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 1 - Related articles - All 2 versions

Les stents coronaires à élution sont-ils dangereux?


E de Benedetti, P URBAN - Revue médicale suisse, 2007 - cat.inist.fr
L'introduction des stents à élution a bouleversé le traitement de la maladie coronarienne. Bien
que leur efficacité pour la prévention de la resténose intra-stent ait été établie, plusieurs présentations
récentes ont suggéré qu'ils comportent un risque accru de thrombose tardive. L'analyse ...
Cited by 1 - Related articles - BL Direct

INTERPRETING THE CHARISMA STUDY: What is the role of dual antiplatelet …


MR BAKHRU, DL BHATT - Cleveland Clinic Journal of Medicine, 2008 - ccjm.highwire.org
The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and
Avoidance (CHARISMA) study (N Engl J Med 2006; 354:1706–1717, J Am Coll Cardiol
2007; 49:1982–1988) assessed the effect of dual antiplatelet therapy with clopidogrel ( ...
Cited by 1 - Related articles - BL Direct - All 7 versions

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi- …


BP Yan, AE Ajani, G New, SJ Duffy, O Farouque, J … - International Journal of …, 2008 - Elsevier
We analysed 672 consecutive patients undergoing percutaneous coronary interventions with
≥ 3.5 mm stent implantation in native coronary artery de-novo lesions from the Melbourne Interventional
Group (MIG) registry. Baseline characteristics, 30-day and 12-month outcomes of patients ...
Cited by 1 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google